65 related articles for article (PubMed ID: 16552173)
1. Ligand-based targeted therapy: a novel strategy for hepatocellular carcinoma.
Li M; Zhang W; Wang B; Gao Y; Song Z; Zheng QC
Int J Nanomedicine; 2016; 11():5645-5669. PubMed ID: 27920520
[TBL] [Abstract][Full Text] [Related]
2. Letter to the Editor: Hepatic interferon regulatory factor 8 expression suppresses HCC progression and enhances the response to anti-programmed cell death protein-1 therapy.
Zhang W; Wang MK; Yao D; Zhao HJ; Zhang XY
Hepatology; 2023 Jul; 78(1):E9-E10. PubMed ID: 36932706
[No Abstract] [Full Text] [Related]
3. Novel ICI-TKI combination improves HCC outcomes.
Killock D
Nat Rev Clin Oncol; 2023 Nov; 20(11):733. PubMed ID: 37563429
[No Abstract] [Full Text] [Related]
4. The epitome of tailor-made short positively charged peptides against HCC via integrated pharmacology.
Oh KK; Eom JA; Lee KJ; Kwon GH; Yoon SJ; Song SH; Park JH; Kim JS; Kim DJ; Suk KT
J Transl Med; 2024 Mar; 22(1):279. PubMed ID: 38491465
[No Abstract] [Full Text] [Related]
5. Circular RNA Hsa_circ_0004018 Inhibits Wnt/β-Catenin Signaling Pathway by Targeting microRNA-626/DKK3 in Hepatocellular Carcinoma.
Zhu P; Liang H; Huang X; Zeng Q; Liu Y; Lv J; Ming L
Onco Targets Ther; 2020; 13():9351-9364. PubMed ID: 33061423
[TBL] [Abstract][Full Text] [Related]
6. Cancer Stem Cell and Gastrointestinal Cancer: Current Status, Targeted Therapy and Future Implications.
Ahmad R; Dhawan P; Singh AB
Biochem Pharmacol (Los Angel); 2016; 5(2):. PubMed ID: 31656694
[TBL] [Abstract][Full Text] [Related]
7. Systems Challenges of Hepatic Carcinomas: A Review.
Madduru D; Ijaq J; Dhar S; Sarkar S; Poondla N; Das PS; Vasquez S; Suravajhala P
J Clin Exp Hepatol; 2019; 9(2):233-244. PubMed ID: 31024206
[TBL] [Abstract][Full Text] [Related]
8. Targeting multiple oncogenic pathways for the treatment of hepatocellular carcinoma.
Swamy SG; Kameshwar VH; Shubha PB; Looi CY; Shanmugam MK; Arfuso F; Dharmarajan A; Sethi G; Shivananju NS; Bishayee A
Target Oncol; 2017 Feb; 12(1):1-10. PubMed ID: 27510230
[TBL] [Abstract][Full Text] [Related]
9. Targeted therapies in the treatment of advanced hepatocellular carcinoma.
Wei Z; Doria C; Liu Y
Clin Med Insights Oncol; 2013; 7():87-102. PubMed ID: 23761989
[TBL] [Abstract][Full Text] [Related]
10. Novel strategies for immunotherapy in multiple myeloma: previous experience and future directions.
Danylesko I; Beider K; Shimoni A; Nagler A
Clin Dev Immunol; 2012; 2012():753407. PubMed ID: 22649466
[TBL] [Abstract][Full Text] [Related]
11. Targeting metastatic upper gastrointestinal adenocarcinomas.
Spratlin JL; Chu Q; Koski S; King K; Mulder K
World J Clin Oncol; 2011 Mar; 2(3):135-49. PubMed ID: 21611088
[TBL] [Abstract][Full Text] [Related]
12. Learning from Jekyll to control Hyde: Hedgehog signaling in development and cancer.
Barakat MT; Humke EW; Scott MP
Trends Mol Med; 2010 Aug; 16(8):337-48. PubMed ID: 20696410
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic regulation of cancer stem cells in liver cancer: current concepts and clinical implications.
Marquardt JU; Factor VM; Thorgeirsson SS
J Hepatol; 2010 Sep; 53(3):568-77. PubMed ID: 20646772
[TBL] [Abstract][Full Text] [Related]
14. Molecular targeted therapies in hepatocellular carcinoma.
Llovet JM; Bruix J
Hepatology; 2008 Oct; 48(4):1312-27. PubMed ID: 18821591
[TBL] [Abstract][Full Text] [Related]
15. Hedgehog signaling in hepatocellular carcinoma: novel therapeutic strategy targeting hedgehog signaling in HCC.
Osipo C; Miele L
Cancer Biol Ther; 2006 Feb; 5(2):238-9. PubMed ID: 16552173
[No Abstract] [Full Text] [Related]
16. Hedgehog signaling in human hepatocellular carcinoma.
Patil MA; Zhang J; Ho C; Cheung ST; Fan ST; Chen X
Cancer Biol Ther; 2006 Jan; 5(1):111-7. PubMed ID: 16397407
[TBL] [Abstract][Full Text] [Related]
17. [New therapeutic target of breast cancer].
Kubo M; Kuroki S; Tanaka M
Nihon Rinsho; 2007 Jun; 65 Suppl 6():142-7. PubMed ID: 17679196
[No Abstract] [Full Text] [Related]
18. Targeting Notch3 in Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Perspectives.
Giovannini C; Bolondi L; Gramantieri L
Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28036048
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic targeting of the Hedgehog-GLI pathway in prostate cancer.
Sanchez P; Clement V; Ruiz i Altaba A
Cancer Res; 2005 Apr; 65(8):2990-2. PubMed ID: 15833820
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
